Common use of Further Acknowledgements Clause in Contracts

Further Acknowledgements. Executive acknowledges that: (i) Executive has been offered a period of at least twenty-one (21)1 calendar days from the date he received this Release within which to review and consider its terms before signing it; (ii) The Company hereby advises the Executive to consult with an attorney prior to executing this Release, and he fully understands this right; (iii) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (iv) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (v) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vi) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (vii) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement, unless he signs and does not revoke this Release; (viii) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ix) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (ia) Executive has been offered a period of at least twenty-one (21)1 calendar days from the date he received this Release within which to review and consider its terms before signing it; (iib) The Company hereby advises the Executive to consult with an attorney prior to executing this Release, and he fully understands this right; (iiic) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (ivd) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law;; 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination. (ve) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vif) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (viig) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement, unless he signs and does not revoke this Release; (viiih) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of R▇▇▇▇▇ ▇. ▇▇▇▇▇▇Apple, President and Chief Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇1▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ixi) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive In addition to acknowledgements elsewhere in this Agreement, Employee further acknowledges and agrees that: (ia) Executive has No inducements, representations, or agreements have been offered a period of made or relied upon to make this Agreement, except as stated in this Agreement; (b) Employee was given at least twenty-one (21)1 calendar 21 days from the date he received of first receipt of this Release within which Agreement on February 16, 2005, to consider the terms and conditions of this Agreement; (i) Employee has carefully read this Agreement and has had sufficient opportunity to review and consider its terms before signing itdeliberate this Agreement with or without counsel of Employee's own choosing; and (ii) any choice by Employee to execute this Agreement without the benefit of counsel was knowing and voluntary; (iid) The Company hereby advises Employee understands the Executive to consult with an attorney prior to executing this Release, terms and he fully understands this right; (iii) Executive has carefully read and understands all of the provisions conditions of this Release Agreements and that he is entering into signs this Release freely, knowingly, and Agreement voluntarily; (ive) Executive is not waiving any rights or claims that may arise after Employee must deliver this Release is executed or any other claims that cannot be waived as a matter of law; (v) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vi) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (vii) Executive is not entitled signed Agreement to the severance benefits set forth in Section 1(a) of the AgreementCompany, unless he signs and does not revoke this Release; (viii) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of Marcy C. Panzer, Cha▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇ ▇▇▇ ▇▇▇▇▇▇▇ard, SE Financial Corp., 1901-03 East Passyu▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and ▇▇▇▇ ▇▇▇▇ ▇▇▇ ▇hairman of the terms Board of the Company receives this executed Agreement no later than 21 days after Employee first receives a copy of this Release Agreement; (f) Employee understands that this Agreement shall not become effective or enforceable until the Revocation Period has expired. Employee further understands, acknowledges and agrees that, in order for Employee's revocation of this Agreement to be effective, Employee's revocation must be made in writing and delivered to Marcy C. Panzer, Ch▇▇▇▇▇▇ ▇▇ ▇▇▇ ▇oard, SE Financial Corp., 1901-03 East Passyun▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇:▇▇ PM EST on the seventh (7th) calendar day after the expiration of the Revocation Period; and (ix) Executive is not relying upon any promisesdate on which Employee signed this Agreement. PLEASE CAREFULLY READ THIS AGREEMENT AND GENERAL RELEASE IN FULL. IT CONTAINS A COVENANT NOT TO SUE AND A GENERAL R▇▇▇ASE OF ALL KNOWN AND UNKNOWN CLAIMS ARISING OUT OF YOUR EMPLOYMENT AND YOUR SEPARATION FROM EMPLOYMENT, inducementsINCLUDING, representationsBUT NOT LIMITED TO, or statements that are not expressly set forth in this Release or the AgreementTHE RELEASE OF ALL CLAIMS UNDER TITLE VII OF THE 1964 CIVIL RIGHTS ACT, THE AMERICANS WITH DISABILITIES ACT, THE AGE DISCRIMINATION IN EMPLOYMENT ACT AS AMENDED BY THE OLDER WORKERS' BENEFIT PROTECTION ACT, AND/OR ANY OTHER FEDERAL OR STATE FAIR EMPLOYMENT OR ANTI-DISCRIMINATION STATUTES OR REGULATIONS. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (ia) Executive has been offered a period of at least twenty-one (21)1 21) calendar days from the date he she received this Release within which to review and consider its terms before signing it; (iib) The Company Executive is hereby advises the Executive advised in writing to consult with an attorney prior to executing this Release, and he she fully understands this right; (iiic) Executive has carefully read and understands all of the provisions of this Release and that he she is entering into this Release freely, knowingly, and voluntarily; (ivd) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (ve) The consideration provided to Executive in consideration for his her execution of this Release is greater than any benefits to which Executive would have been entitled had he she not executed this Release; (vif) Any changes made to this Release before Executive signs it will not entitle him her to an additional twenty-one (21) calendar days to review the new version of this Release; (viig) Executive is not entitled to the severance benefits set forth in Section 1(a1 of the Agreement or the Consulting Fees set forth in Section 2(b) of the Agreement, unless he she signs and does not revoke this Release; (viiih) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Chief Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ixi) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (ia) Executive has been offered a period of at least twenty-one (21)1 21) calendar days from the date he received this Release within which to review and consider its terms before signing it; (iib) The Company Executive is hereby advises the Executive advised in writing to consult with an attorney prior to executing this Release, and he fully understands this right; (iiic) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (ivd) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (ve) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vif) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (viig) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement or the Consulting Fees set forth in Section 2(b) of the Agreement, unless he signs and does not revoke this Release; (viiih) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇P▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Senior Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇1▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ixi) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (ia) Executive has been offered a period of at least twenty-one (21)1 calendar days from the date he received this Release within which to review and consider its terms before signing it; (iib) The Company hereby advises the Executive to consult with an attorney prior to executing this Release, and he fully understands this right;; 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination. (iiic) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (ivd) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (ve) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vif) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (viig) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement, unless he signs and does not revoke this Release; (viiih) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇P▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Senior Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇1▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ixi) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (ia) Executive has been offered a period of at least twenty-one (21)1 21) calendar days from the date he received this Release within which to review and consider its terms before signing it; (iib) The Company Executive is hereby advises the Executive advised in writing to consult with an attorney prior to executing this Release, and he fully understands this right; (iiic) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (ivd) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (ve) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vif) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (viig) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement, unless he signs and does not revoke this Release; (viiih) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Senior Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ixi) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (i) Executive has been offered a period of at least twenty-one (21)1 calendar days from the date he received this Release within which to review and consider its terms before signing it; (ii) The Company hereby advises the Executive to consult with an attorney prior to executing this Release, and he fully understands this right; (iii) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (iv) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (v) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vi) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (vii) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement, unless he signs and does not revoke this Release; (viii) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Senior Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ix) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.

Further Acknowledgements. Executive acknowledges that: (i) Executive has been offered a period of at least twenty-one (21)1 calendar days from the date he received this Release within which to review and consider its terms before signing it; 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination. DB1/ 120506350.4 (ii) The Company hereby advises the Executive to consult with an attorney prior to executing this Release, and he fully understands this right; (iii) Executive has carefully read and understands all of the provisions of this Release and that he is entering into this Release freely, knowingly, and voluntarily; (iv) Executive is not waiving any rights or claims that may arise after this Release is executed or any other claims that cannot be waived as a matter of law; (v) The consideration provided to Executive in consideration for his execution of this Release is greater than any benefits to which Executive would have been entitled had he not executed this Release; (vi) Any changes made to this Release before Executive signs it will not entitle him to an additional twenty-one (21) calendar days to review the new version of this Release; (vii) Executive is not entitled to the severance benefits set forth in Section 1(a) of the Agreement, unless he signs and does not revoke this Release; (viii) Executive may revoke this Release within seven (7) calendar days following its execution (the “Revocation Period”) by notifying the Company in writing, by certified letter delivered to the attention of ▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Executive Vice President, General Counsel, Chief Compliance Officer, Human Resources, and Secretary, Antares Pharma, Inc., ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, and the terms of this Release shall not become effective or enforceable until the day after the expiration of the Revocation Period; and (ix) Executive is not relying upon any promises, inducements, representations, or statements that are not expressly set forth in this Release or the Agreement. 1 If the Executive’s employment is terminated as part of a group termination, then the Executive must be provided with 45 calendar days to consider the Release, and provided with additional information about the employees considered and selected for the group termination.. DB1/ 120506350.4